European Launch of Calprotectin Immunoturbidimetric Assay Announced
ALPCO has launched its FDA-cleared Calprotectin Immunoturbidimetric Assay in Europe and begun a pivotal U.S. clinical trial.
ALPCO has launched its FDA-cleared Calprotectin Immunoturbidimetric Assay in Europe and begun a pivotal U.S. clinical trial.
Roche’s Tina-quant Lp(a) Gen.2 Molarity assay received FDA 510(k) clearance, supporting more precise cardiovascular risk assessment.
A graphene-based biosensor with a molecular carbon intermediate layer has been developed to detect specific biomarkers.
Beckman Coulter expanded the menu of assays for its DxI 9000 Access Immunoassay Analyzer with the recent CE marking of hepatitis tests.
The test is for use with the Triage MeterPro for the quantitative determination of placental growth factor in maternal plasma specimens.Â
The FDA-cleared clozapine assay seeks to redefine the landscape of clozapine therapeutic drug monitoring and patient management.